Editor's Note: Many of you noted that the price for a 10-pound bag of potatoes cited in the lawsuit seems ridiculously high. So we look into the matter further — you can read what we found in this follow-up post.
High-tech spying with satellites. Intimidation. Price fixing.
Paula Cooper, 43, left prison Monday morning, decades after she became America's youngest resident of death row at age 16. She had confessed to the 1985 murder of Bible studies teacher Ruth Pelke, 78, in Gary, Ind. Cooper's death sentence was commuted in 1989, after widespread appeals for mercy.
The human voice appears to trigger pleasure circuits in the brains of typical kids, but not children with autism, a Stanford University team reports. The finding could explain why many children with autism seem indifferent to spoken words.
Once upon a time, it was MySpace. (Huh. Turns out you can still link to it.) Then Facebook happened. And Twitter. And beyond those two dominant social-media platforms, there are a host of other, newer options for staying in touch and letting the digital universe get a look at your life. And for certain kinds of sharing, some of those other options make more sense to tech-savvy teens than the Big Two do.
Note: As part of NPR's series on the summer of 1963, reporter Cory Turner headed to Jackson, Miss. to take a look at how folks are teaching the Civil Rights movement to kids who weren't a part of it — and making the lessons stick.
Much has changed in the past 50 years, since the height of the Civil Rights movement. But how do you teach the Civil Rights to kids who haven't ever experienced it? In Jackson, Miss., Fannie Lou Hamer Institute's Summer Youth Workshop tackles that question.
The man who leaked secret National Security Agency documents, Edward Snowden, defended his decision to reveal details of U.S. surveillance programs in a web chat on Monday. Snowden said he's still in Hong Kong and claims he wouldn't get a fair trial in the U.S. He also said he has not been in contact with the Chinese government and that there are more disclosures to come.
When the maker of a brand-name drug pays a maker of generic drugs to not produce a lower-priced version of their product, the Federal Trade Commission can challenge the arrangement on antitrust grounds, the Supreme Court ruled Monday. The ruling may end the era of what regulators call "pay-for-delay" deals.
The justices voted 5-3 to allow a case to go forward in which the FTC is challenging one of many such deals. Several companies are involved in the case, including Solvay Pharmaceuticals, maker of AndroGel, and generic-drug maker Actavis.